Clinical trials offer hope for hidradenitis suppurativa patients
Clinical trials investigating the efficacy of biologics in treating this condition at Stage 2 and Stage 3 are growing in number and should be considered a front-line treatment option, says this expert.
 
Patients don't talk about hyperhidrosis
Many patients living with hyperhidrosis do so silently, meaning the condition is often left untreated. It's up to dermatologists start the conversation about available treatments when they notice patients’ symptoms, say this expert.
ADVERTISEMENT
 
Legislative, regulatory updates impact dermatology
Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice..
 
Connect with us on Twitter and Facebook for daily updates.
From our Latest Issue
 
Dermatology Times cover
Novel acne cream seeks FDA approval
 
Rosacea, breast cancer possibly linked
 
Apremilast appears safe for children with psoriasis
 
JOB OPPORTUNITIES